Showing results (111-120 of 224) with videos related to
Sort By:
Pageof 23
European Journal of Pharmacology|June 23, 1994
Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated isletsS Gregersen, U Langel, T Bartfai, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 18, 2009
[Workplace health promotion through human resources development part I: development and evaluation of qualification programme for prevention of psychic stresses]A Zimber, S Gregersen, S Kuhnert, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 22, 2010
[Leadership behaviour and health - current research state]S Gregersen, S Kuhnert, A Zimber, et al.American Journal of Physiology. Endocrinology and Metabolism|October 6, 2005
Stevioside counteracts the alpha-cell hypersecretion caused by long-term palmitate exposureJ Hong, L Chen, P B Jeppesen, et al.Diabetes, Obesity & Metabolism|January 19, 2008
Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouseI Nordentoft, P B Jeppesen, J Hong, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1995
Comparison of the effects on the diurnal blood pressure, glucose, and lipid levels of a diet rich in monounsaturated fatty acids with a diet rich in polyunsaturated fatty acids in type 2 diabetic subjectsC Thomsen, O W Rasmussen, K W Hansen, et al.Diabetologia|September 1, 1995
Urinary albumin excretion rate and 24-h ambulatory blood pressure in NIDDM with microalbuminuria: effects of a monounsaturated-enriched dietS Nielsen, K Hermansen, O W Rasmussen, et al.Metabolism: Clinical and Experimental|May 25, 1999
Alcohol and postexercise metabolic responses in type 2 diabetesB M Rasmussen, C Christiansen, O W Rasmussen, et al.Diabetes Care|December 24, 1997
Comparison of a carbohydrate-rich diet and diets rich in stearic or palmitic acid in NIDDM patients. Effects on lipids, glycemic control, and diurnal blood pressureH Storm, C Thomsen, E Pedersen, et al.Diabetes, Obesity & Metabolism|June 27, 2007
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metforminK Hermansen, M Kipnes, E Luo, et al.Pageof 23